IQVIA Holdings, Inc. (IQV) Q2 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

to ask a question during this time, simply press star followed by the number one on your telephone keypad. If you would like to withdraw your question, press the pound key. As a reminder, this call is being recorded. Thank you. I would now like to turn the call over to Kerry Joseph, Senior Vice President, Investor Relations and Treasury. Mr. Joseph, please begin your conference. Thank you, operator. Good morning, everyone. Thank you for joining our second quarter's Today, we will be representing a presentation that will be visible during this call for those of you on our webcast. This presentation will also be available following us on the events and presentations section of our IQVIA Investor Relations website at ir.iqvia.com. Before we begin, I would like to caution listeners that certain information companies' filings with the Securities and Exchange Commission, including our annual report on Form 10-K and subsequent SEC filings. In addition, we will discuss certain non-GAAP financial measures on this call, which should be considered a supplement to and not a substitute for financial measures prepared in accordance with GAAP. A reconciliation of these non-GAAP measures I would now like to turn the call over to our chairman and CEO, Ari Busey. Thank you, Gary, and good morning, everyone. Thank you for joining us today to discuss our second quarter results. As you have delivered another strong quarter, revenue exceeded the high end of our guidance range as we reported over $4 billion in quarterly revenue for the first time in our history. Adjusted EBITDA and adjusted EBITDA came in towards the high end of our guidance range. As expected, TAS continued to perform well in the second quarter, supported by clients' commercial roadmap strategies and new drug launches. TA...